Trial intelligence / Profile preview

Pharmacokinetics of intraperitoneal and intravenous fosfomycin in automated peritoneal dialysis patients

2009-011505-16Phase 2Completed

Sponsor
Medical University of Vienna
Start
May 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of fosfomycin in Renal Insufficiency (RI) and None (2 arms), sponsored by Medical University of Vienna. Primary endpoints: Area under the concentration-time curve (AUC), Maximum concentration (Cmax) and 3 more. Started May 2009; status: completed.

02

Drugs

fosfomycin
03

Conditions

Renal Insufficiency (RI)

Beyond the preview

Go deeper on 2009-011505-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-011505-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call